Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Conditions
Lupus Nephritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Circuit Clinical, Orchard Park, New York, United States
Contact: Principal Investigator (Isha Gupta)Novartis Investigative Site, Vitória, Espírito Santo, Brazil
Novartis Investigative Site, Salvador, Estado de Bahia, Brazil
Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site, Santo André, São Paulo, Brazil
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Shantou, Guangdong, China
Novartis Investigative Site, Shenzhen, Guangdong, China
Novartis Investigative Site, Liuzhou, Guangxi, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Changchun, Jilin, China
Novartis Investigative Site, Binzhou, Shandong, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Chongqing, China
Novartis Investigative Site, Guangzhou, China
Novartis Investigative Site, Guangzhou, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Barranquilla, Atlántico, Colombia
Novartis Investigative Site, Olomouc, Czechia
Novartis Investigative Site, Prague, Czechia
Novartis Investigative Site, Guatemala City, Guatemala
Novartis Investigative Site, Guatemala City, Guatemala
Novartis Investigative Site, Tuenmen, Hong Kong
Novartis Investigative Site, Budapest, Hungary
Novartis Investigative Site, Kuala Lumpur, Kuala Lumpur, Malaysia
Novartis Investigative Site, Sibu, Sarawak, Malaysia
Novartis Investigative Site, León, Guanajuato, Mexico
Novartis Investigative Site, Oaxaca City, Mexico
Novartis Investigative Site, Querétaro, Mexico
Novartis Investigative Site, Bucharest, Romania
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Suwon, Gyeonggi-do, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Taichung, Taiwan
Novartis Investigative Site, Songkhla, Hat Yai, Thailand
Novartis Investigative Site, Bangkok, Thailand
Novartis Investigative Site, Bangkok, Thailand
Novartis Investigative Site, Chiang Mai, Thailand
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals